Puerarin attenuates S. aureus -induced mastitis through inhibiting inflammation and ferroptosis by activating the SIRT1/p53/SLC7A11 signaling pathway
Open Access
- 2 September 2025
- journal article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (9) , e0285924
Abstract
Mastitis, one of the most prevalent diseases in humans and animals, is commonly caused by local infection of the mammary gland. Puerarin inhibits mitochondrial oxidative stress and acute liver injury in mice. However, the therapeutic effect of puerarin on Staphylococcus aureus -induced mastitis is still not well understood. This study was designed to investigate the therapeutic role and mechanism of puerarin on S. aureus -induced mastitis. S. aureus was injected through the mammary gland to induce mouse mastitis. Puerarin was administered to mastitis mice via intraperitoneal injection. The iron concentration was measured using an iron assay. TNF-α and IL-1β levels in the mammary gland tissues were assessed using the ELISA kits. The signaling pathways were detected by western blot analysis. Hematoxylin and eosin staining revealed that puerarin reversed pathological injury to mammary gland tissue induced by S. aureus . Puerarin also inhibited TNF-α and IL-1β production induced by S. aureus . The significant increases in iron concentration, myeloperoxidase activity, and the malondialdehyde (MDA) level in the mammary gland tissue were attenuated by puerarin. Moreover, puerarin treatment significantly reversed the decreases in the relative glutathione (GSH) and GPX4 expression. In addition, puerarin increased the expression of SIRT1 and solute carrier family 7 member 11 (SLC7A11) and decreased p53 expression. In vitro , the inhibitory effects of puerarin on S. aureus -induced inflammation and ferroptosis were prevented by the SIRT1 inhibitor EX-527. In conclusion, the therapeutic mechanism of puerarin involves the activation of the SIRT1/p53/SLC7A11 pathway to inhibit ferroptosis and the inflammatory response. IMPORTANCE: Antibiotics are the main drugs used to treat mastitis, but they can easily cause bacterial resistance and food safety issues. Therefore, finding safe and effective drugs is crucial to prevent and treat mastitis. Puerarin is the main isoflavonoid active ingredient in Pueraria lobata and has a wide range of pharmacological effects. We found that it could attenuate mastitis induced by Staphylococcus aureus .Keywords
This publication has 26 references indexed in Scilit:
- Study on the mechanism of puerarin against osteoarthritis from ferroptosis based on network pharmacology and bioinformaticsNaunyn-Schmiedeberg's Archives of Pharmacology, 2023
- Ferroptosis and Neurodegenerative Diseases: Insights into the Regulatory Roles of SLC7A11Cellular and Molecular Neurobiology, 2023
- Puerarin protects against sepsis-associated encephalopathy by inhibiting NLRP3/Caspase-1/GSDMD pyroptosis pathway and reducing blood-brain barrier damageEuropean Journal of Pharmacology, 2023
- Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathwayFree Radical Biology and Medicine, 2022
- Upregulated-gene expression of pro-inflammatory cytokines (TNF-α, IL-1β and IL-6) via TLRs following NF-κB and MAPKs in bovine mastitisActa Tropica, 2020
- Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and InflammationInflammation, 2020
- Role of GPX4 in ferroptosis and its pharmacological implicationFree Radical Biology and Medicine, 2019
- Puerarin: A Review of Pharmacological EffectsPhytotherapy Research, 2013
- Endocannabinoid Oxygenation by Cyclooxygenases, Lipoxygenases, and Cytochromes P450: Cross-Talk between the Eicosanoid and Endocannabinoid Signaling PathwaysChemical Reviews, 2011
- Staphylococcus aureus capsule and slime as virulence factors in ruminant mastitis. A reviewVeterinary Microbiology, 1994